Trial Profile
A retrospective study of sorafenib treatment following hematopoietic stem cell transplant in paediatric patients with FLT3/ITD+ acute myeloid leukaemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Sep 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 04 Aug 2014 New trial record